Women with suspected diagnosis of ovarian cancer in Ghana: how much do we know about them?
Frontiers in Oncology · 12.03.2026 · 16
DOI: 10.3389/fonc.2026.1771387 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 12.03.2026. Verfasst von Kwabena Amo-Antwi und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Addressing disparities in ovarian cancer care between sub-Saharan Africa and other regions begins with the fundamental question, “Who gets ovarian cancer?” This study aimed to identify the demographic and clinical predictors of cancer among women with ovarian tumours.
Methods
We conducted a cross-sectional analysis of women with histology-confirmed ovarian tumour discussed at a multidisciplinary tumour board in a tertiary hospital in Ghana between 2013 and 2024. Descriptive statistics were used to summarise the characteristics of the women, and logistic regression was performed to identify predictors of ovarian cancer. P≤0.05 was considered statistically significant.
Results
Of the 496 women whose data were analysed, 74.4% (n=369) had ovarian cancer. Women diagnosed with ovarian cancer were older than those without cancer (median age 50 years (36-60) vs 39 years (26-55), p<0.001). Most women (274, 55.3%) were married; 297 (59.9%) were multiparous; 291 (58.7%) were urbanites; and more women with cancer were unemployed (93 vs 8, p=0.023). Most women (281, 56.7%) reported abdominal distension. Women with cancer had anaemia (p<0.001), hypertension, diabetes, or other comorbidities (p=0.012). Of the 127 benign tumours, mature cystic teratomas (50, 39.4%), mucinous tumours (28, 22.0%), serous tumours (20, 15.7%), and ovarian fibromas (12, 12.9%) were common. Few (30, 7.5%) and 3 (0.8%) had immunohistochemical and genetic tests, respectively. Travel distance of 100 km or more, (aOR 2.82; 95% CI: 1.21–6.56) postmenopausal status (aOR 6.43; 95% CI: 1.98–20.92), symptom duration of 3–6 months (aOR 2.85; 95% CI: 1.36–5.95), anaemia (aOR 3.74; 95% CI: 1.93–7.25) and hypertension, diabetes, or other comorbidities (aOR 3.74; 95% CI: 1.93–7.25) were predictors of ovarian cancer. Other predictors were tumours with a solid component (aOR 12.97; 95% CI: 3.16–53.18), vascular flow on imaging (aOR 9.53; 95% CI: 4.63–19.65), ascites (aOR 3.62; 95% CI: 1.84–7.14) and elevated serum CA-125 levels (aOR 4.48; 95% CI: 2.32–8.62).
Conclusion
Most women with ovarian tumours were young, and a significant proportion had benign tumours, highlighting the need for a more thorough diagnostic assessment. Improved gynaecological ultrasound scanning, access to intraoperative pathology consultation and molecular testing will be essential for guiding ovarian cancer care in Ghana.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
- Walter Aiden Specialist Clinic, Asokwa-Kumasi, Ghana.
- Department of Obstetrics and Gynaecology, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
- Department of Adult Health, School of Nursing and Midwifery, University of Ghana, Accra, Ghana.
- Department of Nursing and Midwifery, Garden City University College, Kumasi, Ghana.
- Department of Obstetrics and Gynaecology, Weill Cornell Medical Centre, New York-Presbyterian, New York, NY, United States.
Zitieren
APA
Amo-Antwi, K., Nartey, Y., Agambire, R., Davis-Rivera, L., Haghighat, R., Ocloo, B. W., Appiah-Kubi, A., Agyemang-Prempeh, P., Prempeh, G. O., Dekyi, K., Boakye, A. Y., Dassah, E. T., Tannor, E. K., Ansah, M. B., Akakpo, P. K., Adjei, E., Boateng, N. A., Maxwell, K. N., Adutwum, K. O., …, & Chapman-Davis, E. (2026). Women with suspected diagnosis of ovarian cancer in Ghana: how much do we know about them?. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1771387
Vancouver
Amo-Antwi K, Nartey Y, Agambire R, Davis-Rivera L, Haghighat R, Ocloo BW, et al. Women with suspected diagnosis of ovarian cancer in Ghana: how much do we know about them?. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1771387
BibTeX
@article{AmoAntwi2026,
author = {Amo-Antwi, Kwabena and Nartey, Yvonne and Agambire, Ramatu and Davis-Rivera, Lauren and Haghighat, Roxanna and Ocloo, Bernard Worlasi and Appiah-Kubi, Adu and Agyemang-Prempeh, Philip and Prempeh, George Osei and Dekyi, Kofi and Boakye, Ama Yeboah and Dassah, Edward Tieru and Tannor, Elliot Koranteng and Ansah, Mavis Bobie and Akakpo, Patrick Kafui and Adjei, Ernest and Boateng, Nana Addo and Maxwell, Kofi Nti and Adutwum, Kwabena Oppong and Ampem-Darkwa, Kwasi and Amo, Bismark Dwobeng and Antwi-Kusi, Akwasi and Chapman-Davis, Eloise},
title = {Women with suspected diagnosis of ovarian cancer in Ghana: how much do we know about them?},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1771387}
}
EUVIMED